Related Experiment Video
Updated: Apr 21, 2026
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
1.4K
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis.
Dimitris Mavridis1, Ian R White, Julian P T Higgins
1Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece; Department of Primary Education, University of Ioannina, Ioannina, Greece.
Statistics in Medicine
|November 14, 2014
Summary
This study introduces new methods to address missing outcome data in meta-analyses of randomized controlled trials. The techniques adjust for potentially biased estimates caused by informative missingness, improving treatment effect accuracy.
Area of Science:
- Biostatistics
- Clinical Trials Methodology
- Epidemiology
Background:
- Missing outcome data are frequent in randomized controlled trials (RCTs).
- Complete case analysis (CCA) is a common but potentially biased method for handling missing data.
- Ignoring informative missing data can lead to biased treatment effect estimates in meta-analyses.
Purpose of the Study:
- To develop and present novel methods for estimating meta-analytic summary treatment effects for continuous outcomes with missing data.
- To extend existing methods for binary outcomes to continuous outcomes, quantifying departure from the missing at random (MAR) assumption.
- To provide adjusted estimates of treatment effects and their standard errors, accounting for informative missingness.
Main Methods:
- Developed a new statistical model to quantify informative missingness using either a difference or ratio of means.
- The model relates the mean of missing outcome data to the mean of observed data.
- Employed Taylor series approximation and Monte Carlo methods for estimating adjusted treatment effects and standard errors.
- Applied the methodology to both pairwise and network meta-analyses, including multi-arm trials.
Main Results:
- The proposed methods allow for the estimation of meta-analytic treatment effects adjusted for informative missingness.
- Quantification of the degree of departure from the MAR assumption is achieved through informative missingness measures.
- The methods were successfully applied to real-world meta-analysis examples, demonstrating their practical utility.
Conclusions:
- The developed methods offer a robust approach to handling missing outcome data in meta-analyses of continuous outcomes.
- These techniques can provide less biased and more reliable estimates of treatment effects compared to complete case analysis.
- The study contributes advanced statistical tools for meta-analysis in the presence of missing data, enhancing evidence synthesis.
Related Concept Videos
01:27Confounding in Epidemiological Studies
1.1K
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
1.1K
01:29Bias in Epidemiological Studies
1.7K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.7K
00:59Uncertainty: Overview
2.0K
In analytical chemistry, we often perform repetitive measurements to detect and minimize inaccuracies caused by both determinate and indeterminate errors. Despite the cares we take, the presence of random errors means that repeated measurements almost never have exactly the same magnitude. The collective difference between these measurements - observed values - and the estimated or expected value is called uncertainty. Uncertainty is conventionally written after the estimated or expected value.
2.0K
01:16Bioequivalence Data: Statistical Interpretation
347
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
347
01:15Assumptions of Survival Analysis
503
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
503
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
587
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
587